NCT04406935已完成不适用
Evaluation of the Safety and Efficacy of the NuEra Tight for Abdominal Circumference Reduction
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 32
- 试验地点
- 3
- 主要终点
- Reduction in abdominal circumference
研究概览
简要总结
Clinical study to evaluate the safety and efficacy of the NuEra Tight for circumferential reduction in the abdominal region within three treatment group
详细描述
The study design to evaluate the safety and efficacy of the NuEra Tight for circumferential reduction in the abdominal region within three treatment group. each group has a different radio-frequency. The study hypothesis is that NuEra Tight is safe and will cause a reduction in abdominal circumferential after treatment and at 12 week post last treatment within each treatment group.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Male or Female, 18 to 65 years of age
- •Has visible fat bulges on the abdomen
- •Has a Body Mass Index (BMI) ≤ 30
- •Non-smoking for at least 6 months and willing to refrain from smoking for the duration of the study.
- •Subject must agree to not undergo any other procedure(s) in the abdominal region during the study period.
- •Subject who is willing to refrain from a change in diet/ exercise/medication regimen for the entire course of the study and to maintain his/her weight during the study within 5% of baseline weight measurement.
- •Subject must agree to adhere to the follow-up schedule and study instructions.
- •Subject must be able to read, understand and sign the Informed Consent Form.
- •Willing to have digital photographs taken of the treatment area and agree to use of photographs for presentation, educational or marketing purposes.
- •If the subject is a female and not pregnant or lactating, she must be either post-menopausal, surgically sterilized or using a medically acceptable form of birth control at least 3 months prior to enrolment (i.e oral contraceptives, contraceptive implant, barrier methods with spermicide or abstinence) and during the entire course of the study, and no plans to become pregnant.
排除标准
- •Subject had any type of prior cosmetic treatment to the target area within 12 months of study participation e.g., radiofrequency, cryolipolysis or light-based treatments.
- •Subject had any prior invasive cosmetic surgery to the target area, such as liposuction
- •Subject has scar tissue in and around the treatment area (i.e. cesarean-section or traumatic injury scar)
- •Subject has tattoo(s) that extend over a substantial portion of the treatment area
- •Subject is currently taking medications or supplements for weight-loss or metabolism support/enhancement or has a history of taking such medications or supplements within 3 months.
- •Has a pacemaker, internal defibrillator, implantable cardioverter-defibrillator, nerve stimulator implant, cochlear implant or any other electronically, magnetically or mechanically activated implant.
- •Has metal implant(s) within the body, such as surgical clips, plates and screws, intrauterine device (IUD), artificial heart valves or artificial joints.
- •History of diseases stimulated by heat, such as recurrent herpes zoster in the treatment area, unless treatment is conducted following a prophylactic regimen.
- •History of any disease or condition that could impair wound healing.
- •Infection, dermatitis, rash or other skin abnormality in the target area.
- •History of keloid formation, hypertrophic scarring or abnormal/delayed wound healing
- •History of hypertension, ischemic heart disease, valvular heart disease, congestive heart failure, and abdominal aortic aneurysm
- •Significant concurrent illness, such as diabetes mellitus, hyperlipidemia, liver disease, HIV positive, blood coagulopathy or excessive bleeding, autoimmune or connective tissue disease, cardiovascular disease, peripheral vascular disease or pertinent neurological disorders.
- •History of skin disease in the treatment area or known epidermal or dermal disorders (particularly if involving collagen or microvascularity)
- •Severe skin laxity in the treatment area
- •Extensive collection of visceral adipose tissue or abdominal wall diastasis or hernia on physical examination
- •Obesity ≥30 BMI
- •Diagnosed or documented immune system disorders.
- •Currently undergoing systemic chemotherapy or radiation treatment for cancer, or history of treatment in the target area within 3 months of study participation.
- •Participation in a clinical trial of another device or drug within 6 months of study participation, or during the study period.
- •Pregnant or currently breastfeeding.
- •As per the Investigator's discretion, any physical or mental condition which might make it unsafe for the subject to participate in this study.
- •Known allergy to general and/or topical anesthetic
结局指标
主要结局
Reduction in abdominal circumference
时间窗: one month
Change in abdominal circumference in cm
次要结局
未报告次要终点
研究者
研究点 (3)
Loading locations...
相似试验
尚未招募
不适用
Reduced tooth sensitivity using toothpastes with 8% arginine and low-power laserDentin hypersensitivityC07.793.266RBR-25f7scniversidade Luterana do Brasil
招募中
Unknown
Clinical study comparing short-diameter implants with 3.5 mm diameter to long-diameter implants with 5.0 mm diameter for implant placementKCT0009415Yonsei University Health System, Dental Hospital20
已完成
不适用
A Clinincal study to assess the effect of an ayurvedic polyherbal formulation in the treating patients with flu like symptomsCTRI/2020/12/029600Clinfound Clinical Research Services Pvt Ltd30
已完成
Unknown
A clinical study to evaluate the safety & efficacy of test product in Healthy Female subjectsCTRI/2023/06/053620DPKA Universal Consumer Venture Private Limited55
尚未招募
3 期
A clinical study for relieving pain and restoring mobility of joints in the patients of Frozen shoulder, calcaneal spur, knee osteoarthritis, tennis elbow with the help of electrocautery to radiate heat around painful site and achieve results.CTRI/2020/08/027159Shri Ayurved College